Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Demarest

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Journal of Molecular Biology|November 11, 1999
Defining the core structure of the alpha-lactalbumin molten globule stateS J Demarest, J A Boice, R Fairman, et al.
Journal of Biomolecular NMR|May 23, 2002
Assignment of a 15 kDa protein complex formed between the p160 coactivator ACTR and CREB binding proteinStephen J Demarest, John Chung, H Jane Dyson, et al.
Biochimica Et Biophysica Acta|December 22, 1999
Local interactions and the role of the 6-120 disulfide bond in alpha-lactalbumin: implications for formation of the molten globule stateD F Moriarty, S J Demarest, J Robblee, et al.
Proteins|January 3, 2013
Highly covarying residues have a functional role in antibody constant domainsElizabeth A Proctor, Pradeep Kota, Stephen J Demarest, et al.
Protein Science : a Publication of the Protein Society|December 24, 2003
Packing, specificity, and mutability at the binding interface between the p160 coactivator and CREB-binding proteinStephen J Demarest, Songpon Deechongkit, H Jane Dyson, et al.
Journal of Molecular Biology|December 11, 2012
Metric to distinguish closely related domain families using sequence informationElizabeth A Proctor, Pradeep Kota, Stephen J Demarest, et al.
Biochemistry|May 1, 2001
A comparative study of peptide models of the alpha-domain of alpha-lactalbumin, lysozyme, and alpha-lactalbumin/lysozyme chimeras allows the elucidation of critical factors that contribute to the ability to form stable partially folded statesS J Demarest, S Q Zhou, J Robblee, et al.
Mabs|July 4, 2024
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapyAmelia C McCue, Stephen J Demarest, Karen J Froning, et al.
Journal of Structural Biology|September 3, 2013
Influence of canonical structure determining residues on antibody affinity and stabilityLouis A Clark, Stephen J Demarest, John Eldredge, et al.
Nature|February 2, 2002
Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivatorsStephen J Demarest, Maria Martinez-Yamout, John Chung, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Journal of Molecular Biology|November 11, 1999
Defining the core structure of the alpha-lactalbumin molten globule stateS J Demarest, J A Boice, R Fairman, et al.
Journal of Biomolecular NMR|May 23, 2002
Assignment of a 15 kDa protein complex formed between the p160 coactivator ACTR and CREB binding proteinStephen J Demarest, John Chung, H Jane Dyson, et al.
Biochimica Et Biophysica Acta|December 22, 1999
Local interactions and the role of the 6-120 disulfide bond in alpha-lactalbumin: implications for formation of the molten globule stateD F Moriarty, S J Demarest, J Robblee, et al.
Proteins|January 3, 2013
Highly covarying residues have a functional role in antibody constant domainsElizabeth A Proctor, Pradeep Kota, Stephen J Demarest, et al.
Protein Science : a Publication of the Protein Society|December 24, 2003
Packing, specificity, and mutability at the binding interface between the p160 coactivator and CREB-binding proteinStephen J Demarest, Songpon Deechongkit, H Jane Dyson, et al.
Journal of Molecular Biology|December 11, 2012
Metric to distinguish closely related domain families using sequence informationElizabeth A Proctor, Pradeep Kota, Stephen J Demarest, et al.
Biochemistry|May 1, 2001
A comparative study of peptide models of the alpha-domain of alpha-lactalbumin, lysozyme, and alpha-lactalbumin/lysozyme chimeras allows the elucidation of critical factors that contribute to the ability to form stable partially folded statesS J Demarest, S Q Zhou, J Robblee, et al.
Mabs|July 4, 2024
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapyAmelia C McCue, Stephen J Demarest, Karen J Froning, et al.
Journal of Structural Biology|September 3, 2013
Influence of canonical structure determining residues on antibody affinity and stabilityLouis A Clark, Stephen J Demarest, John Eldredge, et al.
Nature|February 2, 2002
Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivatorsStephen J Demarest, Maria Martinez-Yamout, John Chung, et al.
Pageof 7